Literature DB >> 24143036

Cyclizations of phenylethyl-substituted pyridinecarboxaldehydes.

Rajasekhar Reddy Naredla1, Douglas A Klumpp.   

Abstract

Several phenylethyl-substituted pyridinecarboxaldehydes were prepared from 2-bromo-3-pyridinecarboxaldehyde and these substances are found to undergo cyclization reactions in acidic media. In the absence of added nucleophile, acid promoted cyclization and oxidation (MnO2) provides an efficient route to 10,11-dihydro-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-ones. Arene nucleophiles may also be added to the acidic mixture to provide good yields of triarylmethane products. Mechanisms are proposed involving dicationic superelectrophilic intermediates.

Entities:  

Keywords:  Cycloheptabenzopyridine; Friedel-Crafts; Heterocycle; Superacid; Superelectrophile

Year:  2013        PMID: 24143036      PMCID: PMC3797624          DOI: 10.1016/j.tet.2013.01.004

Source DB:  PubMed          Journal:  Tetrahedron        ISSN: 0040-4020            Impact factor:   2.457


  17 in total

1.  Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine.

Authors:  J J Kaminski; N I Carruthers; S C Wong; T M Chan; M M Billah; S Tozzi; A T McPhail
Journal:  Bioorg Med Chem       Date:  1999-07       Impact factor: 3.641

2.  Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines.

Authors:  J J Piwinski; J K Wong; M J Green; A K Ganguly; M M Billah; R E West; W Kreutner
Journal:  J Med Chem       Date:  1991-01       Impact factor: 7.446

3.  Antitumor 8-chlorobenzocycloheptapyridines: a new class of selective, nonpeptidic, nonsulfhydryl inhibitors of ras farnesylation.

Authors:  A K Mallams; F G Njoroge; R J Doll; M E Snow; J J Kaminski; R R Rossman; B Vibulbhan; W R Bishop; P Kirschmeier; M Liu; M S Bryant; C Alvarez; D Carr; L James; I King; Z Li; C C Lin; C Nardo; J Petrin; S W Remiszewski; A G Taveras; S Wang; J Wong; J Catino; A K Ganguly
Journal:  Bioorg Med Chem       Date:  1997-01       Impact factor: 3.641

4.  NHC-catalyzed oxidative cyclization reactions of 2-alkynylbenzaldehydes under aerobic conditions: synthesis of O-heterocycles.

Authors:  Jong Hyub Park; Sachin V Bhilare; So Won Youn
Journal:  Org Lett       Date:  2011-03-29       Impact factor: 6.005

5.  A multiplicity of anti-invasive effects of farnesyl transferase inhibitor SCH66336 in human head and neck cancer.

Authors:  Seung Hyun Oh; Ju-Hee Kang; Jong Kyu Woo; Ok-Hee Lee; Edward S Kim; Ho-Young Lee
Journal:  Int J Cancer       Date:  2012-01-31       Impact factor: 7.396

6.  Discovery of a 5H-benzo[4,5]cyclohepta[1,2-b]pyridin-5-one (MK-2461) inhibitor of c-Met kinase for the treatment of cancer.

Authors:  Jason D Katz; James P Jewell; David J Guerin; Jongwon Lim; Christopher J Dinsmore; Sujal V Deshmukh; Bo-Sheng Pan; C Gary Marshall; Wei Lu; Michael D Altman; William K Dahlberg; Lenora Davis; Danielle Falcone; Ana E Gabarda; Gaozhen Hang; Harold Hatch; Rachael Holmes; Kaiko Kunii; Kevin J Lumb; Bart Lutterbach; Robert Mathvink; Naim Nazef; Sangita B Patel; Xianlu Qu; John F Reilly; Keith W Rickert; Craig Rosenstein; Stephen M Soisson; Kerrie B Spencer; Alexander A Szewczak; Deborah Walker; Wenxian Wang; Jonathan Young; Qinwen Zeng
Journal:  J Med Chem       Date:  2011-05-24       Impact factor: 7.446

7.  Stereoselective synthesis of desloratadine derivatives as antagonist of histamine.

Authors:  Gai-Zhi Liu; Hai-Wei Xu; Guang-Wei Chen; Peng Wang; Ya-Na Wang; Hong-Min Liu; De-Quan Yu
Journal:  Bioorg Med Chem       Date:  2010-01-04       Impact factor: 3.641

8.  Design and synthesis of thiourea derivatives containing a benzo[5,6]cyclohepta[1,2-b]pyridine moiety as potential antitumor and anti-inflammatory agents.

Authors:  Wukun Liu; Jinpei Zhou; Tong Zhang; Haiyang Zhu; Hai Qian; Huibin Zhang; Wenlong Huang; Ronald Gust
Journal:  Bioorg Med Chem Lett       Date:  2012-03-08       Impact factor: 2.823

9.  A novel iodide-catalyzed reduction of nitroarenes and aryl ketones with H3PO2 or H3PO3: its application to the synthesis of a potential anticancer agent.

Authors:  George G Wu; Frank X Chen; Danny LaFrance; Zhijian Liu; Scott G Greene; Yee-Shing Wong; Ji Xie
Journal:  Org Lett       Date:  2011-08-26       Impact factor: 6.005

10.  [(3-Pyridylalkyl)piperidylidene]benzocycloheptapyridine derivatives as dual antagonists of PAF and histamine.

Authors:  E Carceller; M Merlos; M Giral; D Balsa; C Almansa; J Bartrolí; J García-Rafanell; J Forn
Journal:  J Med Chem       Date:  1994-08-19       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.